Sign in to view content

Direct-to-Consumer Marketing by U.S. Cell Therapy Clinics for Retinal Conditions

Ajay E Kuriyan, MD, MS

Video
Published 2018

Related

A Real-World Analysis in 49,485 Eyes of Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Neovascular AMD Patients
David F. Williams, MD, MBA
Annual Meeting Talks
2018
Pyron Award, “Treating AMD: Back to the Future”, Joan W. Miller, MD
Joan W. Miller, MD
Annual Meeting Talks
2018
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022

Category: Age-Related Macular Degeneration

See more